Introgen Clinical Trial Chosen for Publication in `Best of the Journal Of Clinical Oncology`
(PR Newswire)...``Adenovirus-Mediated p53 Gene Transfer in Sequence with Cisplatin to Tumors of Patients with Non-......Three patents cover gene therapy of cancer using a p53 tumor suppressor gene in combination with one or more chemotherapeutic drugs,......Introgen is also conducting a Phase II clinical trial for INGN 201 in lung cancer and Phase I trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder, brain, and breast cancer....- May 30 7:30 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010530/daw007.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines